Silicon Laboratories Inc.
| |||
| Nine Months Ended | ||
| October 1, 2022 |
| October 2,
|
Operating Activities |
|
|
|
Net income | $ 66,041 |
| $2,120,497 |
Adjustments to reconcile net income to net cash provided by operating activities of continuing operations: |
|
|
|
Income from discontinued operations, net of income taxes | -- |
| (2,183,884) |
Depreciation of property and equipment | 16,514 |
| 12,925 |
Amortization of other intangible assets | 27,328 |
| 33,971 |
Amortization of debt discount and debt issuance costs | 1,492 |
| 17,278 |
Loss on extinguishment of convertible debt | 3 |
| 3,370 |
Stock-based compensation expense | 43,213 |
| 36,916 |
Equity-method earnings | (2,985) |
| (5,938) |
Deferred income taxes | (13,126) |
| (3,132) |
Changes in operating assets and liabilities: |
|
|
|
Accounts receivable | 21,641 |
| 22,573 |
Inventories | (39,100) |
| (11,320) |
Prepaid expenses and other assets | (28,404) |
| 33,536 |
Accounts payable | 26,694 |
| (4,522) |
Other current liabilities and income taxes | 17,962 |
| (10,981) |
Deferred revenue and returns liability | (2,144) |
| (1,657) |
Other non-current liabilities | (7,713) |
| (11,388) |
Net cash provided by operating activities of continuing operations | 127,416 |
| 48,244 |
|
|
|
|
|
|
|
|
Investing Activities |
|
|
|
Purchases of marketable securities | (579,507) |
| (1,212,572) |
Sales of marketable securities | 42,952 |
| 194,492 |
Maturities of marketable securities | 597,399 |
| 173,924 |
Purchases of property and equipment | (20,057) |
| (19,468) |
Purchases of other assets | -- |
| (578) |
Net cash provided by (used in) investing activities of continuing operations | 40,787 |
| (864,202) |
|
|
|
|
|
|
|
|
Financing Activities |
|
|
|
Payments on debt | (21) |
| (140,572) |
Repurchases of common stock | (681,695) |
| (688,373) |
Payment of taxes withheld for vested stock awards | (14,732) |
| (21,393) |
Proceeds from the issuance of common stock | 6,366 |
| 8,619 |
Net cash used in financing activities of continuing operations | (690,082) |
| (841,719) |
|
|
|
|
|
|
|
|
Discontinued Operations |
|
|
|
Operating activities | (69,467) |
| 69,685 |
Investing activities | -- |
| 2,747,684 |
Net cash provided by (used in) discontinued operations | (69,467) |
| 2,817,369 |
|
|
|
|
|
|
|
|
Increase (decrease) in cash and cash equivalents | (591,346) |
| 1,159,692 |
Cash and cash equivalents at beginning of period | 1,074,623 |
| 202,720 |
Cash and cash equivalents at end of period | $ 483,277 |
| $1,362,412 |
Silicon Labs Grows Revenue 46% in Third Quarter 2022
![]() ![]() |
|
RELATED NEWS
Latest Blog Posts
Team ShareCG
by Team ShareCG
Change in payment schedule for Vendors !!!